Advertisement
Screener

Merck & Co., Inc. (MRK) Share-based Payment Arrangement, Expense, Tax Benefit

2.2 / 5 stars · 50/112 Roast Me

Merck & Co., Inc. Share-based Payment Arrangement, Expense, Tax Benefit

Merck & Co., Inc. (MRK) reported Share-based Payment Arrangement, Expense, Tax Benefit of $125.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Expense Statement › Income Tax

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-02-24

  • Merck & Co., Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2021-03-31 was $17.00M, a 13.33% increase year-over-year.
  • Merck & Co., Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2020-12-31 was $17.00M, a 13.33% increase year-over-year.
  • Merck & Co., Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2020-09-30 was $17.00M, a 21.43% increase year-over-year.
  • Merck & Co., Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2020-06-30 was $16.00M, a 6.67% increase year-over-year.
  • Merck & Co., Inc. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $125.00M, a 6.84% increase from fiscal 2024.
  • Merck & Co., Inc. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $117.00M, a 21.88% increase from fiscal 2023.
  • Merck & Co., Inc. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $96.00M, a 23.08% increase from fiscal 2022.
  • Merck & Co., Inc. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $78.00M, a 13.04% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Expense, Tax Benefit 3 monthShare-based Payment Arrangement, Expense, Tax Benefit 3 month as first filedShare-based Payment Arrangement, Expense, Tax Benefit 6 monthShare-based Payment Arrangement, Expense, Tax Benefit 6 month as first filedShare-based Payment Arrangement, Expense, Tax Benefit 9 monthShare-based Payment Arrangement, Expense, Tax Benefit 9 month as first filedShare-based Payment Arrangement, Expense, Tax Benefit 12 month
2025-12-31$125.00M
10-K · filed 2026-02-24
2024-12-31$117.00M
10-K · filed 2026-02-24
2023-12-31$96.00M
10-K · filed 2026-02-24
2022-12-31$78.00M
10-K · filed 2025-02-25
2021-12-31$69.00M
10-K · filed 2024-02-26
2021-03-31$17.00M
10-Q · filed 2021-05-05
$34.00M
derived: sum of 2 quarters · filed 2023-02-24
$51.00M
derived: sum of 3 quarters · filed 2023-02-24
$67.00M
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31$17.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$34.00M
derived: sum of 2 quarters · filed 2023-02-24
$50.00M
derived: sum of 3 quarters · filed 2023-02-24
$65.00M
10-K · filed 2023-02-24
2020-09-30$17.00M
10-Q · filed 2020-11-05
$33.00M
derived: sum of 2 quarters · filed 2020-11-05
$48.00M
10-Q · filed 2020-11-05
$63.00M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$16.00M
10-Q · filed 2020-08-05
$31.00M
10-Q · filed 2020-08-05
$46.00M
derived: sum of 3 quarters · filed 2022-02-25
$60.00M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$15.00M
10-Q · filed 2021-05-05
$30.00M
derived: sum of 2 quarters · filed 2022-02-25
$44.00M
derived: sum of 3 quarters · filed 2022-02-25
$59.00M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$15.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$29.00M
derived: sum of 2 quarters · filed 2022-02-25
$44.00M
derived: sum of 3 quarters · filed 2022-02-25
$57.00M
10-K · filed 2022-02-25
2019-09-30$14.00M
10-Q · filed 2020-11-05
$29.00M
derived: sum of 2 quarters · filed 2020-11-05
$42.00M
10-Q · filed 2020-11-05
$56.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$15.00M
10-Q · filed 2020-08-05
$28.00M
10-Q · filed 2020-08-05
$42.00M
derived: sum of 3 quarters · filed 2021-02-25
$56.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$14.00M
10-Q · filed 2020-05-06
$27.00M
derived: sum of 2 quarters · filed 2021-02-25
$41.00M
derived: sum of 3 quarters · filed 2021-02-25
$54.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$13.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$27.00M
derived: sum of 2 quarters · filed 2021-02-25
$40.00M
derived: sum of 3 quarters · filed 2021-02-25
$55.00M
10-K · filed 2021-02-25
2018-09-30$14.00M
10-Q · filed 2019-11-05
$27.00M
derived: sum of 2 quarters · filed 2019-11-05
$42.00M
10-Q · filed 2019-11-05
$29.00M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$13.00M
10-Q · filed 2019-08-06
$28.00M
10-Q · filed 2019-08-06
$15.00M
derived: sum of 3 quarters · filed 2020-02-26
$38.00M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$15.00M
10-Q · filed 2019-05-08
$2.00M
derived: sum of 2 quarters · filed 2020-02-26
$25.00M
derived: sum of 3 quarters · filed 2020-02-26
$50.00M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31-$13.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$10.00M
derived: sum of 2 quarters · filed 2020-02-26
$35.00M
derived: sum of 3 quarters · filed 2020-02-26
$57.00M
10-K · filed 2020-02-26
2017-09-30$23.00M
10-Q · filed 2018-11-06
$48.00M
derived: sum of 2 quarters · filed 2018-11-06
$70.00M
10-Q · filed 2018-11-06
$93.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30$25.00M
10-Q · filed 2018-08-07
$47.00M
10-Q · filed 2018-08-07
$70.00M
derived: sum of 3 quarters · filed 2019-02-27
$94.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$22.00M
10-Q · filed 2018-05-08
$45.00M
derived: sum of 2 quarters · filed 2019-02-27
$69.00M
derived: sum of 3 quarters · filed 2019-02-27
$94.00M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$23.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$47.00M
derived: sum of 2 quarters · filed 2019-02-27
$72.00M
derived: sum of 3 quarters · filed 2019-02-27
$92.00M
10-K · filed 2019-02-27
2016-09-30$24.00M
10-Q · filed 2017-11-07
$49.00M
derived: sum of 2 quarters · filed 2017-11-07
$69.00M
10-Q · filed 2017-11-07
$93.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$25.00M
10-Q · filed 2017-08-08
$45.00M
10-Q · filed 2017-08-08
$69.00M
derived: sum of 3 quarters · filed 2018-02-27
$92.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$20.00M
10-Q · filed 2017-05-09
$44.00M
derived: sum of 2 quarters · filed 2018-02-27
$67.00M
derived: sum of 3 quarters · filed 2018-02-27
$93.00M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$24.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$47.00M
derived: sum of 2 quarters · filed 2018-02-27
$73.00M
derived: sum of 3 quarters · filed 2018-02-27
$93.00M
10-K · filed 2018-02-27
2015-09-30$23.00M
10-Q · filed 2016-11-07
$49.00M
derived: sum of 2 quarters · filed 2016-11-07
$69.00M
10-Q · filed 2016-11-07
$90.00M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$26.00M
10-Q · filed 2016-08-08
$45.00M
10-Q · filed 2016-08-08
$67.00M
derived: sum of 3 quarters · filed 2017-02-28
$90.00M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$19.00M
10-Q · filed 2016-05-09
$41.00M
derived: sum of 2 quarters · filed 2017-02-28
$64.00M
derived: sum of 3 quarters · filed 2017-02-28
$88.00M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$22.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$45.00M
derived: sum of 2 quarters · filed 2017-02-28
$69.00M
derived: sum of 3 quarters · filed 2017-02-28
$86.00M
10-K · filed 2017-02-28
2014-09-30$23.00M
10-Q · filed 2015-11-05
$47.00M
derived: sum of 2 quarters · filed 2015-11-05
$64.00M
10-Q · filed 2015-11-05
$84.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$24.00M
10-Q · filed 2015-08-06
$41.00M
10-Q · filed 2015-08-06
$61.00M
derived: sum of 3 quarters · filed 2016-02-26
$82.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$17.00M
10-Q · filed 2015-05-07
$37.00M
derived: sum of 2 quarters · filed 2016-02-26
$58.00M
derived: sum of 3 quarters · filed 2016-02-26
$81.00M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$20.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$41.00M
derived: sum of 2 quarters · filed 2016-02-26
$64.00M
derived: sum of 3 quarters · filed 2016-02-26
$84.00M
10-K · filed 2016-02-26
2013-09-30$21.00M
10-Q · filed 2014-11-10
$44.00M
derived: sum of 2 quarters · filed 2014-11-10
$64.00M
10-Q · filed 2014-11-10
$88.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$23.00M
10-Q · filed 2014-08-07
$43.00M
10-Q · filed 2014-08-07
$67.00M
derived: sum of 3 quarters · filed 2015-02-27
$95.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$20.00M
10-Q · filed 2014-05-08
$44.00M
derived: sum of 2 quarters · filed 2015-02-27
$72.00M
derived: sum of 3 quarters · filed 2015-02-27
$101.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$24.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$52.00M
derived: sum of 2 quarters · filed 2015-02-27
$81.00M
derived: sum of 3 quarters · filed 2015-02-27
$105.00M
10-K · filed 2015-02-27
2012-09-30$28.00M
10-Q · filed 2013-11-07
$57.00M
derived: sum of 2 quarters · filed 2013-11-07
$81.00M
10-Q · filed 2013-11-07
$100.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$29.00M
10-Q · filed 2013-08-07
$53.00M
10-Q · filed 2013-08-07
$72.00M
derived: sum of 3 quarters · filed 2014-02-27
$102.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$24.00M
10-Q · filed 2013-05-09
$43.00M
derived: sum of 2 quarters · filed 2014-02-27
$73.00M
derived: sum of 3 quarters · filed 2014-02-27
$110.00M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31$19.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
$49.00M
derived: sum of 2 quarters · filed 2014-02-27
$86.00M
derived: sum of 3 quarters · filed 2014-02-27
$118.00M
10-K · filed 2014-02-27
2011-09-30$30.00M
10-Q · filed 2012-11-09
$67.00M
derived: sum of 2 quarters · filed 2012-11-09
$99.00M
10-Q · filed 2012-11-09
$136.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$37.00M
10-Q · filed 2012-08-07
$69.00M
10-Q · filed 2012-08-07
$106.00M
derived: sum of 3 quarters · filed 2013-02-28
$148.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$32.00M
10-Q · filed 2012-05-08
$69.00M
derived: sum of 2 quarters · filed 2013-02-28
$111.00M
derived: sum of 3 quarters · filed 2013-02-28
$160.00M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$37.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$79.00M
derived: sum of 2 quarters · filed 2013-02-28
$128.00M
derived: sum of 3 quarters · filed 2013-02-28
$173.00M
10-K · filed 2013-02-28
2010-09-30$42.00M
10-Q · filed 2011-11-08
$42.30M
10-Q · filed 2010-11-08
$91.00M
derived: sum of 2 quarters · filed 2011-11-08
$136.00M
10-Q · filed 2011-11-08
$135.90M
10-Q · filed 2010-11-08
$178.40M
derived: sum of 4 quarters · filed 2012-02-28
2010-06-30$49.00M
10-Q · filed 2011-08-08
$48.70M
10-Q · filed 2010-08-06
$93.00M
10-Q · filed 2011-08-08
$93.60M
10-Q · filed 2010-08-06
$136.40M
derived: sum of 3 quarters · filed 2012-02-28
$163.10M
derived: sum of 4 quarters · filed 2012-02-28
2010-03-31$45.00M
10-Q · filed 2011-05-09
$87.40M
derived: sum of 2 quarters · filed 2012-02-28
$114.10M
derived: sum of 3 quarters · filed 2012-02-28
$140.60M
derived: sum of 4 quarters · filed 2012-02-28
2009-12-31$42.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$69.10M
derived: sum of 2 quarters · filed 2012-02-28
$95.60M
derived: sum of 3 quarters · filed 2012-02-28
$132.00M
10-K · filed 2012-02-28
2009-09-30$26.70M
10-Q · filed 2010-11-08
$53.20M
derived: sum of 2 quarters · filed 2010-11-08
$89.60M
10-Q · filed 2010-11-08
2009-06-30$26.50M
10-Q · filed 2010-08-06
$62.90M
10-Q · filed 2010-08-06
2008-12-31$108.00M
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60